Description
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), investigated in endocrine and metabolic research. Its structure is based on the GHRH(1–44) sequence with an N-terminal modification designed to increase stability. This 20mg listing identifies a separate catalogue quantity within the tesamorelin range.
Mechanism & Research Background
Tesamorelin acts at the GHRH receptor, upstream of growth hormone release, rather than directly replacing growth hormone. Published studies have examined growth hormone-axis activity alongside measurements of visceral adipose tissue and liver fat in defined clinical populations. Those findings provide research context; they do not establish general fat-loss benefits or equivalence between a research catalogue material and the formulations used in those trials.
Areas of Research
- GHRH receptor activity and growth hormone-axis responses.
- Relationships between endocrine measurements and metabolic endpoints.
- Comparative study of stabilised GHRH analogues.
The 20mg entry contains a different listed quantity from the 10mg entry, rather than a different receptor mechanism. Comparisons should use the actual analytical content and study concentration, not assume a different biological effect from the pack label. Clinical findings remain specific to the formulations and populations investigated.
Product Details
- Product: Tesamorelin 20mg
- Listed quantity: 20mg
- Compound class: Growth hormone-releasing hormone analogue
- Product code: TSM20
Storage & Handling
Follow the storage conditions and handling guidance in the applicable supplier documentation. Protect the material from unsuitable heat, light and moisture, and record the batch used in each experiment. Preparation and storage requirements depend on the supplied formulation and the research method.
Batch Documentation
Certificates of analysis should be matched to the product and batch. Consult the relevant report for measured identity, content and purity; a purity result alone does not establish sterility or endotoxin status.
Research References
Important Notice
Premium research peptides synthesised and shipped from Australia. For in-vitro research purposes only. Strictly not for human or veterinary consumption. All products supplied are strictly for laboratory research and development. This information describes the compound’s research background and does not provide dosing instructions or claim a therapeutic benefit.






Reviews
There are no reviews yet.